Detalles de la búsqueda
1.
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Prostate
; 84(5): 473-478, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38149793
2.
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
Eur J Nucl Med Mol Imaging
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861182
3.
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials.
BJU Int
; 133(2): 158-168, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422731
4.
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
Curr Opin Urol
; 34(4): 294-299, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587018
5.
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer.
World J Urol
; 41(8): 2069-2076, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37326656
6.
What to expect from the novel pulsed thulium:YAG laser? A systematic review of endourological applications.
World J Urol
; 41(11): 3301-3308, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37682286
7.
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.
J Urol
; 204(2): 296-302, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068488
8.
Ho:YAG laser and temperature: is it safe to use high-power settings?
World J Urol
; 40(7): 1891-1892, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438313
10.
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
Eur Urol Oncol
; 7(2): 231-240, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37689506
11.
Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer.
Eur Urol Open Sci
; 52: 40-43, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182120
12.
Understanding the Role of Ureteral Access Sheath in Preventing Post-Operative Infectious Complications in Stone Patients Treated with Ureteroscopy and Ho:YAG Laser Lithotripsy: Results from a Tertiary Care Referral Center.
J Clin Med
; 12(4)2023 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835992
13.
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Mol Cancer Res
; 21(1): 51-61, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112348
14.
Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series.
Eur Urol Oncol
; 6(5): 493-500, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005213
15.
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
Eur Urol Focus
; 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865591
16.
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.
Cancers (Basel)
; 15(7)2023 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046687
17.
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Eur Urol Oncol
; 6(6): 543-552, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37270378
18.
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol
; 2023 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845121
19.
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis.
Cancer Treat Rev
; 110: 102441, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35939976
20.
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation.
Front Oncol
; 12: 955894, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36132135